Company intelligence / Profile preview
Cessatech
Copenhagen, Denmarkcessatech.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Phase 3
01
Overview
Cessatech’s lead product, CT001, is an analgesic nasal spray designed to treat acute pain in children. It leverages more than ten years of clinical experience with the active compound. The company uses a de-risked approach by repositioning existing medicines to fit pediatric needs, resulting in shorter development timelines and higher likelihood of regulatory success. Recent milestones include completion of pivotal studies and positive regulatory opinions under EU MDR
- Therapeutic areas
- OtherNeurology
- Modalities
- Nasal sprays (drug-device combination)Local anesthetic gel
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Proveca Ltd.: Exclusive commercial partnership worldwide excluding the US for CT001Ventis Pharma Corporation – collaboration/license agreement on formulation/pain management therapies
Beyond the preview
Go deeper on Cessatech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cessatech.